Skip to main content

Peer Review reports

From: CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer

Original Submission
23 Nov 2022 Submitted Original manuscript
29 Nov 2022 Author responded Author comments - Jillian Howlin
30 Nov 2022 Author responded Author comments - Jillian Howlin
Resubmission - Version 2
29 Nov 2022 Submitted Manuscript version 2
3 Mar 2023 Reviewed Reviewer Report - Himanshi Tanwar
7 Mar 2023 Reviewed Reviewer Report
2 Apr 2023 Author responded Author comments - Jillian Howlin
Resubmission - Version 3
2 Apr 2023 Submitted Manuscript version 3
3 Apr 2023 Author responded Author comments - Jillian Howlin
Resubmission - Version 4
3 Apr 2023 Submitted Manuscript version 4
10 Apr 2023 Reviewed Reviewer Report - Himanshi Tanwar
14 Apr 2023 Reviewed Reviewer Report
1 Jun 2023 Author responded Author comments - Jillian Howlin
Resubmission - Version 5
1 Jun 2023 Submitted Manuscript version 5
Publishing
2 Jun 2023 Editorially accepted
15 Jun 2023 Article published 10.1186/s13104-023-06376-1

You can find further information about peer review here.

Back to article page